Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 8
1984 13
1985 62
1986 101
1987 38
1988 48
1989 39
1990 44
1991 57
1992 41
1993 42
1994 27
1995 30
1996 30
1997 37
1998 31
1999 27
2000 18
2001 15
2002 19
2003 12
2004 24
2005 20
2006 17
2007 17
2008 10
2009 15
2010 15
2011 5
2012 16
2013 19
2014 8
2015 17
2016 21
2017 12
2018 10
2019 8
2020 13
2021 21
2022 10
2023 9
2024 4

Search Results

1,008 results

Results by year

Filters applied: . Clear all
Page 1
Cilastatin Ameliorates Rhabdomyolysis-induced AKI in Mice.
Matsushita K, Mori K, Saritas T, Eiwaz MB, Funahashi Y, Nickerson MN, Hebert JF, Munhall AC, McCormick JA, Yanagita M, Hutchens MP. Matsushita K, et al. J Am Soc Nephrol. 2021 Oct;32(10):2579-2594. doi: 10.1681/ASN.2020030263. Epub 2021 Aug 2. J Am Soc Nephrol. 2021. PMID: 34341182 Free PMC article.
Imipenem-cilastatin.
Dinsmoor MJ. Dinsmoor MJ. Obstet Gynecol Clin North Am. 1992 Sep;19(3):475-82. Obstet Gynecol Clin North Am. 1992. PMID: 1436925 Review.
New evidence in severe pneumonia: imipenem/ cilastatin/relebactam.
Girón RM, Ibáñez A, Gómez-Punter RM, Alarcón T. Girón RM, et al. Rev Esp Quimioter. 2022 Apr;35 Suppl 1(Suppl 1):46-49. doi: 10.37201/req/s01.11.2022. Epub 2022 Apr 22. Rev Esp Quimioter. 2022. PMID: 35488826 Free PMC article. Review.
A Randomized, Double-blind, Multicenter Trial Comparing Efficacy and Safety of Imipenem/Cilastatin/Relebactam Versus Piperacillin/Tazobactam in Adults With Hospital-acquired or Ventilator-associated Bacterial Pneumonia (RESTORE-IMI 2 Study).
Titov I, Wunderink RG, Roquilly A, Rodríguez Gonzalez D, David-Wang A, Boucher HW, Kaye KS, Losada MC, Du J, Tipping R, Rizk ML, Patel M, Brown ML, Young K, Kartsonis NA, Butterton JR, Paschke A, Chen LF. Titov I, et al. Clin Infect Dis. 2021 Dec 6;73(11):e4539-e4548. doi: 10.1093/cid/ciaa803. Clin Infect Dis. 2021. PMID: 32785589 Free PMC article. Clinical Trial.
Pharmacokinetics, Safety, and Tolerability of Imipenem/Cilastatin/Relebactam in Children with Confirmed or Suspected Gram-Negative Bacterial Infections: A Phase 1b, Open-Label, Single-Dose Clinical Trial.
Bradley JS, Makieieva N, Tøndel C, Roilides E, Kelly MS, Patel M, Vaddady P, Maniar A, Zhang Y, Paschke A, Chen LF. Bradley JS, et al. J Clin Pharmacol. 2023 Dec;63(12):1387-1397. doi: 10.1002/jcph.2334. Epub 2023 Sep 2. J Clin Pharmacol. 2023. PMID: 37562063 Clinical Trial.
1,008 results